Clinical Trials

Ongoing Clinical Trials

Clinical Trials Currently Recruiting Patients:

Dermatology Research Registry 

If you are interested in possibly participating in any of our current or future research studies, please sign up for our Dermatology Research Registry online at:    https://studypages.com/uncderm

 

Your information will be kept confidential and will only be used to contact you about potential research studies.  Your information will not be shared.

 

Psoriasis Research Study (Oral Medication)

Requirements: Adult patients (18-75) with moderate to severe psoriasis.  Additional treatments other than the study treatment are not permitted during the study period.  


Duration: 11 total visits in a 1-6 week screening period, 12 week treatment period, and an 8 week follow-up period.


Incentive: Subject compensation available.  Study treatment, which could be active drug or placebo, study-related exams, and lab tests will be provided at no cost. 

 

Sponsor: Supported by Pfizer

 

For more information please contact:    Laura Keck
                                                                    984-974-3682
                                                                    
laura_mcleod@med.unc.edu

 

Epidermolysis Bullosa Simplex (EBS) Research Study (Topical) Medication


Requirements: Patients (4+) with epidermolysis bullosa simplex. Additional treatments
other than the study medication are not permitted during the study period.

Duration: 8 total visits, 3 day to 6 week screening period, 8 week treatment period, plus a follow-up visit 4 weeks and 8 weeks after completing therapy.

Incentive: Subject compensation and travel assistance available. Study medication, study related exams, and lab tests will be provided at no cost.

Sponsor: Supported by Castle Creek Pharmaceuticals LLC


For more information please contact:

Laura Keck
984-974-3682
laura_mcleod@med.unc.edu


Pediatric Psoriasis Research Study (Topical Medication)


Requirements: Pediatric patients (2-11 years) with mild to moderate plaque type psoriasis affecting the body and scalp.  Additional treatments other than the study medication are not permitted during the study period.  
Duration: 4 total visits, 2 week screening period, 8 week treatment period, plus a follow-up phone call one week after the last study visit.
Incentive: Subject compensation available.  Study medication, study-related exams, and lab tests will be provided at no cost. 

 

Sponsor: Supported by Stiefel, a GSK company

 

For more information please contact:    Laura Keck
                                                                    984-974-3682
                                                                   
lmcleod@email.unc.edu

 

 

 

Your Physician:
Aida Lugo-Somolinos, MD
Link to Dr. Lugo-Somolinos' Research